Trial Profile
Effect of Steady State TPV/r 500 mg/200 mg on Intracellular Concentrations of Zidovudine Triphosphate and Carbovir Triphosphate
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 05 Sep 2014 New trial record